Advertisement
Advertisement

COEP

COEP logo

Coeptis Therapeutics Holdings Inc

13.45
USD
+1.06
+8.55%
Jan 30, 14:59 UTC -5
Open

Coeptis Therapeutics Holdings Inc Profile

About

Coeptis Therapeutics Holdings Inc., together with its subsidiaries including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals Inc., is a biopharmaceutical company developing innovative cell therapy platforms for cancer. Coeptis Therapeutics Holdings Inc., formerly known as Bull Horn Holdings Corp., is based in WEXFORD, Pa.

Info & Links

CEO

David Mehalick

Headquarters

105 BRADFORD ROAD, SUITE 420
WEXFORD, PA 15090, UNITED STATES

Auditor

Turner, Stone & Company, LLP

Share holders

112

Employees

7

Coeptis Therapeutics Holdings Inc Statistics

Valuation Measures

Market Capitalization2

553.06M

Enterprise Value

553.63M

Enterprise Value/EBITDA(ttm)

-54.77

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.97

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-1094.50%

Return on Invested Capital(ttm)

1774.12%

Return on Assets(ttm)

-219.97%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-10.11M

Net Income Available to Common(ttm)

-11.62M

Diluted EPS(ttm)

-5.80

Share Statistics

Beta (5Y Monthly)

-1.04

52-Week Change

1020.83%

S&P 500 52-Week Change

25.29%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

2.06M

Dividend Yield

0.00%

Float4

1.82M

% Held by Insiders

24.25%

% Held by Institutions

13.88%

Balance Sheet

Total Cash(mrq)

1.14M

Total Cash Per Share(mrq)

0.55

Total Debt(mrq)

1.70M

Total Debt/Equity(mrq)

34.20%

Current Ratio(mrq)

0.40%

Quick Ratio(mrq)

0.40%

Book Value Per Share(mrq)

2.49

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.62

Free Cash Flow(ytd)

-5.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement